Brief: Basilea Pharmaceutica Announces Cresemba® Sales In Asia Pacific Region Trigger Sales Milestone Payment For This Region
June 17 (Reuters) - BASILEA PHARMACEUTICA AG BSLN.S :
* CRESEMBA® SALES IN ASIA PACIFIC REGION TRIGGER SALES
MILESTONE
PAYMENT TO BASILEA FROM PFIZER
* UNDER AGREEMENT WITH PFIZER, BASILEA IS ELIGIBLE FOR
ADDITIONAL
REGULATORY AND SALES MILESTONE PAYMENTS OF UP TO AROUND CHF 550
MILLION, IN ADDITION TO RECEIVING MID-TEEN ROYALTIES ON SALES
Source text for Eikon: ID:nGNEHn7cg
Further company coverage: BSLN.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Basilea Pharmaceutica AG, Allschwil
See all newsBrief: Basilea Pharmaceutica - Strong Cresemba Sales In Europe Trigger USD 37.5 Mln Milestone Payment
Basilea seen up after raising 2026 guidance
Brief: Basilea Expects 2026 Operating Profit Of CHF 115 Mln
Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments